Advertisement
New expert guidance underscores need for response scalability
$2M NIH grant will help see if dual-action agent lengthens treatment window
Q&A with Dr. Andrew Russman, Medical Director of our Comprehensive Stroke Center
SARS-CoV-2’s potential for neuroinvasion and primary emerging neurologic features
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Minority Stroke Program focuses on outreach to racial and ethnic minority communities
From B-PROUD to EXTEND-IA TNK to a novel TMS delivery method
Large cohort study finds much lower stroke rate than recent database analyses
What we know (and don't know) from published research
Noninvasive assessment of carotid artery plaque composition
30-day risk assessed among 100,000+ TAVR patients in U.S.
Advertisement
Advertisement